Skip to main content

Konstantinos Economopoulos, MD, PhD

House Staff
Start Year: 
2017
College/University: 
University of Athens, School of Medicine
Medical School: 
University of Athens School of Medicine

Clinical and Research Interests

  • Clinical: Bariatric surgery, endocrine surgery, and thoracic surgery
  • Research: Biodesign and surgical innovation

What were you looking for in a residency program?

  • Track record of academic achievements and high clinical volume

What are the strengths of the Duke program?

Duke has the culture, energy, clinical volume, and research opportunities to shape an all-around training experience for the general surgery resident who aspires to become a future leader in Surgery.

What advice do you have for incoming interns?

If you are looking for a place to work hard and push yourself above and beyond your limits then consider Duke Surgery for your training. 

What do you like best about living in Durham and the Triangle?

Durham is one of the few places in the Unites States where a top-notch academic institution is actually located in an area with amazing weather that you can afford to live in and raise a family while you are in-training. The Triangle offers a surprisingly number of opportunities for outdoor activities and entertainment for kids and adults.

What do you like to do outside of Duke?

I like to play with my kids, watch movies, and run outdoors.

Honors and Awards

  • Poster of Merit Award from the Office of Research Career Development at Massachusetts General Hospital (05/2013)
  • Distinction in scholarship award from the American Physiological Society (06/2014)
  • American Thyroid Association Trainees' Grant (07/2014)

Publications

Dahabreh, I. J., and K. P. Economopoulos. “Tamoxifen for the prevention of breast cancer development: an updated meta-analysis.” In Breast Cancer Research and Treatment, 106:S181–S181. SPRINGER, 2007.

Scholars@Duke

Economopoulos, K. P., I. J. Dahabreh, and S. Murray. “2039 POSTER Radiotherapy after breast conserving surgery for ductal carcinoma in situ: an overview of randomized trials.” In European Journal of Cancer Supplements, 5:196–196. Elsevier BV, 2007. https://doi.org/10.1016/s1359-6349(07)70801-7.

Full Text

Papaconstadopoulou, I. C., K. P. Economopoulos, P. S. Bouzika, J. A. Botis, and I. J. Dahabreh. “2071 POSTER High dose chemotherapy with marrow or stem cell transplantation versus conventional chemotherapy for breast cancer: an overview of randomized trials.” In European Journal of Cancer Supplements, 5:205–205. Elsevier BV, 2007. https://doi.org/10.1016/s1359-6349(07)70833-9.

Full Text

Bouzika, S. P., I. J. Dahabreh, K. P. Economopoulos, I. C. Papaconstadopoulou, and J. A. Botis. “2084 POSTER Acute myeloid leukaemia and myelodysplastic syndrome after taxane-based adjuvant chemotherapy for early breast cancer: an exploratory meta-analysis.” In European Journal of Cancer Supplements, 5:208–208. Elsevier BV, 2007. https://doi.org/10.1016/s1359-6349(07)70846-7.

Full Text

Dahabreh, I. J., and K. P. Economopoulos. “6578 POSTER No evidence of an association between EGFR inhibitor treatment and interstitial lung disease in patients with advanced lung cancer.” In European Journal of Cancer Supplements, 5:381–82. Elsevier BV, 2007. https://doi.org/10.1016/s1359-6349(07)71406-4.

Full Text

Economopoulos, Konstantinos P., Samuel Murray, and Issa J. Dahabreh. “Ovarian ablation or ovarian suppression versus chemotherapy for hormone receptor positive operable breast cancer: A meta-analysis.” In Annals of Oncology, 18:161–62. OXFORD UNIV PRESS, 2007.

Scholars@Duke

Dahabreh, Issa J., Konstantinos P. Economopoulos, and Samuel Murray. “Trastuzumab with adjuvant chemotherapy for resectable breast cancer: A meta-analysis.” In Annals of Oncology, 18:166–166. OXFORD UNIV PRESS, 2007.

Scholars@Duke

Pages